Filter
4169
Filtered Results: 4169
Text search:
AIDS
response
Featured
Recommendations
331
New Publications
1241
Language
Document type
No document type
2928
Studies & Reports
500
Guidelines
350
Manuals
140
Strategic & Response Plan
108
Training Material
48
Fact sheets
45
Infographics
21
Situation Updates
17
Resource Platforms
6
Brochures
3
Online Courses
3
Countries / Regions
India
202
Kenya
155
South Africa
110
Global
108
Zambia
104
Malawi
101
Uganda
98
Ethiopia
95
Nigeria
92
Nepal
90
Tanzania
85
Liberia
73
Sierra Leone
70
Myanmar / Burma
69
Rwanda
65
Western and Central Europe
60
Namibia
59
Africa
57
Zimbabwe
56
Bangladesh
56
Lesotho
56
Ghana
55
Ukraine
51
Philippines
36
Indonesia
35
Asia
35
Eastern Europe
34
Latin America and the Carribbean
32
Cambodia
30
Botswana
28
Mozambique
27
South–East Asia Region
26
Congo, Democratic Republic of
25
Russia
25
Senegal
24
Eswatini/ Swaziland
22
East and Southern Africa
20
Burkina Faso
17
Cameroon
16
Venezuela
14
Pakistan
13
South Sudan
13
Syria
13
Brazil
13
Haiti
12
Albania
12
Tajikistan
12
West and Central Africa
11
Middle East and North Africa
11
Guinea
10
Georgia
10
Germany
9
Thailand
9
Angola
7
Paraguay
7
Moldova
7
USA
6
Lebanon
6
China
6
North Macedonia
6
Vietnam
6
Papua New Guinea
5
Benin
5
Colombia
5
Western Pacific Region
5
Armenia
5
Southern Africa
5
Jordan
4
Afghanistan
4
Central African Republic
4
Peru
4
Madagascar
4
Yemen
4
Mali
3
Guinea-Bissau
3
Somalia
3
Iraq
3
Argentina
3
Serbia
3
Kyrgyzstan
3
Jamaica
3
Egypt
2
Chad
2
Sudan
2
Hungary
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Poland
2
Laos
2
Bulgaria
2
Estonia
2
Romania
2
Iran
2
Uzbekistan
2
Kazakhstan
2
North America
2
Japan
2
Portugal
2
Morocco
1
Niger
1
Togo
1
Turkey
1
Gambia
1
Singapore
1
Croatia
1
Burundi
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Mexico
1
Fiji
1
Bhutan
1
Canada
1
Timor Leste/ East Timor
1
Slovakia
1
Gabon
1
Turkmenistan
1
Belgium
1
Norway
1
Spain
1
Azerbaijan
1
Belarus
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1806
Clinical Guidelines
268
Women & Child Health
182
Public Health
175
Key Resources
110
Capacity Building
91
Pharmacy & Technologies
38
Annual Report MEDBOX
2
Toolboxes
HIV
815
TB
309
Mental Health
189
COVID-19
175
Disability
174
Caregiver
81
Ebola
60
AMR
60
Health Financing Toolbox
57
Conflict
54
Global Health Education
47
Rapid Response
46
Pharmacy
44
Refugee
42
NTDs
41
Planetary Health
40
Natural Hazards
34
NCDs
25
Cholera
23
Polio
19
Specific Hazards
13
Social Ethics
11
Zika
9
South Sudan
1
Health Financing
1
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
What are the FP and CAC competencies?
Through the clear articulation of the family planning and comprehensive abortion care (FP and CAC) competencies for the primary health care workforce, the aim is to advance improvements in FP and CAC service delivery by aligning health worker education approach...
This document, Programme and curriculum development guide, presents a systematic approach to developing programmes and curricula for implementation of the family planning (FP) and comprehensive abortion care (CAC) competencies,and the theory behind the approach. Specifically, the aim is for effectiv...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
Those who clean are the first line of defense against health care-associated infections (HAIs), and support efforts to reduce antimicrobial resistance (AMR).
Strengthening the training of this important group can contribute to resolving many of today’s public health challenges. This is importan...
Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and
death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t...
This training guide is designed to enable participants to understand the human rights perspective on migration, and how human rights laws and standards can be operationalized to make migration safer and an empowering experience for all. It provides an introduction to related principles and issues an...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
